Takeda Pharmaceutical Company - Core Respiratory Business - Ownership and Business Overview

Life ScienceCompany

Takeda Pharmaceutical Company - Core Respiratory Business Ownership

Who owns Takeda Pharmaceutical Company - Core Respiratory Business?

Takeda Pharmaceutical Company - Core Respiratory Business is owned by AstraZeneca. It was acquired on December 16, 2015.

Takeda Pharmaceutical Company - Core Respiratory Business Business Overview

Where is Takeda Pharmaceutical Company - Core Respiratory Business headquartered?

Takeda Pharmaceutical Company - Core Respiratory Business is headquartered in Japan.

How many employees does Takeda Pharmaceutical Company - Core Respiratory Business have?

Takeda Pharmaceutical Company - Core Respiratory Business has 200 employees.

What sector is Takeda Pharmaceutical Company - Core Respiratory Business in?

Takeda Pharmaceutical Company - Core Respiratory Business is a life science company.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Takeda Pharmaceutical Company - Core Respiratory Business


Japan,

Takeda Pharmaceutical Company Limited's core respiratory business includes the expansion of rights to roflumilast (marketed as Daliresp in the US and Daxas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).


 Subscribe to unlock this and 209,068
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Takeda Pharmaceutical Company - Core Respiratory Business

Life Science Companies , Japan Companies